Skip To Main Content

Science at Sanofi

Discover a wide variety of articles, videos, podcasts, accredited courses, applications, conferences and scientific events in different therapeutic areas.

Sort by

Filters

Reset
  • Therapeutical Areas
  • Type of Content
The ATOS Study: Real-World Study on Effectiveness of Insulin Glargine U300 in the Gulf Region.

The ATOS Study: Real-World Study on Effectiveness of Insulin Glargine U300 in the Gulf Region.

What Are the Signs and Symptoms of ASMD?

What Are the Signs and Symptoms of ASMD?

An Evidence about The Role of Basal Insulin Glargine 300 U/mL Post-GLP-1 Therapy

An Evidence about The Role of Basal Insulin Glargine 300 U/mL Post-GLP-1 Therapy

Connectivity Canvas: Pioneering Diabetes Management with Connected Insulin Caps

Connectivity Canvas: Pioneering Diabetes Management with Connected Insulin Caps

EVOLUTION: RWE from Saudi Arabia

EVOLUTION: RWE from Saudi Arabia

Advancing Therapy with iGlarLixi: Differentiation from complex insulin regimens

Advancing Therapy with iGlarLixi: Differentiation from complex insulin regimens

Advancing Therapy with iGlarLixi: Differentiation from other complex regimens

Advancing Therapy with iGlarLixi: Differentiation from other complex regimens

Challenges associated with commonly-used insulin advancement options

Challenges associated with commonly-used insulin advancement options

Treatment simplification of complex insulin regimens in T2D

Treatment simplification of complex insulin regimens in T2D

Insulin advancement in Type 2 diabetes: Unmet needs with commonly-used options

Insulin advancement in Type 2 diabetes: Unmet needs with commonly-used options

Glargine 300 use in people with type 2 diabetes who fast during Ramadan

Glargine 300 use in people with type 2 diabetes who fast during Ramadan

Gaucher

Gaucher